Hamburg – SEFE Securing Energy for Europe GmbH (SEFE) has acquired all the shares in WIGA Transport Beteili­gungs-GmbH & Co. KG (WIGA) from its co-shareholder Wintershall Dea AG. The transaction is currently awaiting approval from the competition authorities. SEFE is wholly owned by the Federal Republic of Germany. WIGA owns regulated gas pipeline operators GASCADE Gastransport GmbH and NEL Gastransport GmbH, who operate one of the largest high-pressure gas networks in Germany with a combined length of around 4,150 kilometres. These networks have a key role to play in European energy security and the green energy transformation. The transaction will strengthen SEFE in its role of ensuring secure and reliable energy supply in Germany and Europe, as well as boosting its hydrogen ex­pert­ise.“With the full acquisition of WIGA as sole shareholder, we are strategically strengthening SEFE as an independent and autonomous midstream company,” commented Reinhard Gorenflos, Chairman of the SEFE Supervisory Board.“SEFE being the sole shareholder of WIGA will ensure that GASCADE can convert the existing high-performance infrastructure to hydrogen in the future. In this way, we can help drive forward the green energy transformation. Transportation infrastructure is a pivotal part of the future hydrogen value chain,” said Dr Egbert Laege, CEO of SEFE. “The two WIGA subsidiaries, GASCADE and NEL, will continue to operate independently and market their capacity in a transparent and non-dis­crim­in­at­ory manner.”SEFE CFO Dr Christian Ohlms highlighted the importance of WIGA with regard to the privatisation of SEFE, which is due to take place by the end of 2028: “With this transaction, which is expected to complete by summer 2024, we are strengthening SEFE’s asset base. Our aim is to continue the long-term development of SEFE on a stable financial footing.”A multinational CMS team headed by Hamburg-based partner Dr Holger Kraft advised SEFE on all aspects of acquiring WIGA. In addition to extensive due diligence on the entire WIGA Group, including GASCADE and NEL, which are regulated under energy law, this work covered negotiation of the share purchase agreement and separate agreements with the shareholders of Wintershall Dea AG. Alongside negotiating the transaction agreements, the advice focused on safeguarding the transaction through several W&I insurance agreements, including negotiating the policies, and handling regulatory issues relating to gas network operation and other public-law matters. CMS Germany worked closely with the CMS law firms in the UK and Luxembourg, and with US law firm Faegre Drinker Biddle & Reath LLP. CMS previously advised the Federal Network Agency (BNetzA) and the Federal Ministry for Economic Affairs and Climate Action in 2022 and 2023 around their trusteeship over SEFE and its subsequent nationalisation by way of corporate actions. The instructions for this transaction followed on from that successful cooperation. About SEFE:As an integrated midstream energy company headquartered in Berlin, SEFE Securing Energy for Europe ensures the security of energy supply in Germany and Europe and is driving the green energy transformation. SEFE is active in trading & portfolio management, sales, transportation and storage of energy and has its strongest presence in Germany and the UK. SEFE employs around 1,500 people and supplies over 50,000 customers, in particular industrial customers and municipal utilities in Germany and seven other European markets. With a sales volume of around 200 TWh of power and gas, SEFE plays a central role in stability of the energy supply in Germany and Europe. SEFE is owned by the Federal Government of Germany. CMS Germany Dr Holger Kraft, Lead Partner Dr Jan Schepke, Partner Matthias Sethmann, Principal Counsel Dr Dirk Baukholt, Principal Coun­sel Char­lotte von der Heydt-von Kalckreuth, Counsel Dr Stefan Kühl, Senior Associate Dr Paul Kintrup, Senior Associate, all Corporate/M&A Dr Rolf Hempel, Partner Dr Friedrich von Burchard, Partner Nicole Köppen, Senior Associate, all Regulatory Dr Hermann Müller, Partner Dr Arno Görlitz, Associate, both Public Commercial Law Dr Martin Mohr, Partner Dr Olaf Thießen, Principal Counsel, both Tax Dr Alexandra Schluck-Amend, Partner Manuel Nann, Senior As­so­ci­ate Pit-Jo­hannes Wagner, Associate, all Restructuring Dr Andreas Hofelich, Partner Dr Mario Brungs, Counsel Dr Lena Pingen, Associate, all Em­ploy­ment/Pen­sions Dr Fritz von Hammerstein, Partner Jan Gröschel, Senior Associate Heike Weyer, Senior Associate, all Public Law Dr Stefan Voß, Partner Tamara Bux, Associate, both Real Estate Dr Sebastian Cording, Partner Martin Krause, Partner Dr Shaya Stender, Associate Joel Coché, Associate, all Commercial Dr Julia Runge, Principal Counsel, Finance Dr Michael Bauer, Part­ner Chris­toff Henrik Soltau, Partner Dr Robert Bodewig, Senior Associate Luisa Thomasberger, Associate, all Antitrust, Competition & Trade CMS UK Russel Hoare, Partner Sam De Silva, Part­ner Jean-Fran­cois Willems, Of Counsel Jennifer Louch, Senior As­so­ci­ate Max­imili­an Weaver, Senior Associate Louisa Mottaz, Associate CMS Luxembourg Angelique Eguether, Senior As­so­ci­ate Guil­laume Flagollet, Managing Associate Faegre Drinker Biddle & Reath LLP (USA) Mollie D. Sitkowski Inhouse at SEFE Securing Energy for Europe GmbH Dr Jörg Kammerer Jörn RimkePress Con­tact presse@cms-hs. com

Stuttgart – The founder of medical laboratory MVZ Laaff, Prof. Helmut Laaff, has sold MVZ Laaff GmbH with its facilities in Freiburg, Heilbronn and Ulm to the amedes Group. amedes is a leading German lab services provider, operating a number of healthcare centres throughout Germany with different specialisations. MVZ Laaff provides services in fields of medicine including derma­to­path­o­logy, general pathology, immunohistology, molecular pathology and cytology, and is one of the leading laboratories in these specialist areas. Details of the transaction were not disclosed.A CMS team headed by lead partner Dr Christoph Lächler advised Prof. Helmut Laaff on all legal aspects of the transaction. The sale took place by way of an auction process. A particular focus of the advice was on structuring the transaction and the associated regulatory issues. CMS Germany Dr Christoph Lächler, Lead Part­ner Stefan-Ul­rich Müller, Partner Dr Jacob Siebert, Partner Viktoria Barthel, Senior Associate Tobias Kalski, Senior As­so­ci­ate An­dreas Kazmaier, Associate, all Corporate/M&A Dr Roland Wiring, Partner Dr Siham Hidar, Senior Associate, both Regulatory Dr Harald Kahlenberg, Partner Angelika Wieczorkowski, Senior Associate, both Antitrust, Competition & Trade Dr Stefan Voss, Partner Lukas Potstada, Counsel, both Real Estate Dr Martin Mohr, Partner, TaxPress Con­tact presse@cms-hs. com

Stuttgart – The families that own Pforzheim-based Carl Benzinger GmbH have sold a majority interest to Syngroh Capital GmbH, the investment firm set up by the entrepreneurial Klaus Grohe family. The current owners, the Jehle families, will retain a significant minority stake in Carl Benzinger GmbH and continue to manage the company operationally. The majority stake taken by Syngroh Capital will provide Benzinger with a long-term entrepreneurial partner who will contribute to the engineering company’s growth. Details of the transaction were not disclosed.A CMS team headed by lead partner Dr Claus-Peter Fabian advised the family owners of Carl Benzinger GmbH on all legal aspects of the transaction. Carl Benziger GmbH is a leading manufacturer of high-precision lathes and milling machines for a variety of industries, including the watchmaking and jewellery industries as well as sectors such as optics, precision mechanics, medical, dental, electrical and control technology, fluid and bearing technology, the automotive supply industry and aerospace. Benzinger offers everything from a single source – from engineering and building or setting up the machine tools through to after-sales service. The company’s customers include both local firms and world-famous luxury brands. CMS Germany Dr Claus-Peter Fabian, Lead Part­ner Kath­ar­ina Ivic, Senior Associate Julia Fünfgeld, Senior Associate Dr Maximilian Eitelbuß, Senior Associate, all Corporate/M&A Dr Martin Mohr, Partner Tobias Wacker, Associate, both Tax Dr Michael Rein, Principal Counsel, Labor, Employment & Pensions Dr Michael Kraus, Partner, TMC Dr Stefan Voß, Partner Lukas Potstada, Counsel, both Real Estate & Public Thomas Fröhlich, Counsel, IP Lisa Mattmann, Senior Legal Specialist, Smart OperationsPress Con­tact presse@cms-hs. com

Stuttgart – The future of Weck, a company whose history goes back some 123 years, has been secured. Globally active alternative investment group AURELIUS emerged as the successful bidder in a competitive...

Stuttgart – Modine, a diversified global leader in innovative thermal management technology and solutions, has divested three automotive businesses in Germany and sold to affiliates of Regent LP. The...

Stuttgart – The SYNLAB Group has acquired the WolfartKlinik hospital in Gräfelfing near Munich from the Wolfart family. The transaction was agreed in February 2023 and has now been successfully completed...

Stuttgart – CMS, led by M&A partner Dr Tobias Grau, advised Chart Industries, Inc. (NYSE: GTLS) (“Chart”) on the completed acquisition of Howden, a leading global provider of mission critical air...

Stuttgart – On 16 March 2022, the local court in Ravensburg (acting as an insolvency court) handed down a ruling confirming the insolvency plan submitted in July 2021. This confirmation fulfils a key...

Brus­sels/Stut­tgart – The public-sector shareholders of Friedrichshafen Airport (the federal state of Baden-Württem­berg, administrative district of Bodenseekreis and city of Friedrichshafen) have been...

Stuttgart – Private equity firm Premium Equity Partners has acquired Human Med AG, a technology leader in lipoedema treatment and regenerative medicine. Premium Equity Partners is acquiring the company...